Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Transamerica

MCVAX Expense Ratio & Fees

Ticker MCVAX · Since 2014-04-30 · · Holdings as of Jul 31, 2026

Expense ratio
1.18%$118/yr per $10k
5-yr return
+7.2%annualized
1-yr return
+3.5%as of Dec 2025
Net assets
$775.5Mall share classes
Holdings
70

Bottom line

What is MCVAX's expense ratio?

MCVAX's expense ratio is 1.18%, or about $118 a year on every $10,000 invested. That is more expensive than 75% of mid-cap funds we track (median 0.88%). This share class also charges a front-end sales load of up to 5.5%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.

Updated Feb 27, 2026

MCVAX fee table

Net expense ratio1.18%
Gross expense ratio1.18%
Management fee0.69%
12b-1 (distribution) fee0.25%
Other expenses0.24%
Max front-end sales load5.5%
Max deferred sales charge0%

Source: Fund prospectus fee table, filed Feb 27, 2026

What MCVAX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
MCVAX$664$904$1,163$1,903

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 1.18% expense ratio costs roughly $64,300 in lost growth, versus about $49,300 for the median mid-cap fund (0.88%).

Cheapest way to own Transamerica Mid Cap Value Opportunities

All share classes
TickerClassExpense ratioFront load
TOTTXI30.75%0%
MVTRXR60.75%0%
IAAEXI20.75%0%
MVTIXI0.85%0%
TOTFXR40.9%0%
MCVAXA1.18%5.5%
TOTRXR1.24%0%
MCVCXC1.87%0%